CN103768244A - Drug for treating cataract - Google Patents
Drug for treating cataract Download PDFInfo
- Publication number
- CN103768244A CN103768244A CN201210412093.XA CN201210412093A CN103768244A CN 103768244 A CN103768244 A CN 103768244A CN 201210412093 A CN201210412093 A CN 201210412093A CN 103768244 A CN103768244 A CN 103768244A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- raw material
- concha haliotidis
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating the cataract, which is prepared from the following raw materials by weight: 10-30 g of angelica, 6-15 g of radix bupleuri, 10-20 g of fructus leonuri, 10-25 g of fructus lycii, 10-25 g of plantain seed, 15-35 g of concha haliotidis, 15-25 g of semen cassiae, 15-35 g of selfheal, and 3-10 g of liquorice. The drug adopts the main medicines of concha haliotidis and the semen cassiae, and other auxiliary medicines, wherein the main medicines and the auxiliary medicines affect one another and have synergistic effects, so that the good effects of reducing fever and cooling blood, soothing the liver and rectifying the spleen, clearing away the heart-fire and tonifying the kidney are taken, and the drug has a good treatment effect on the cataract, the raw materials are simple, both symptomas and root causes are treated, the cost is low, and the taking is convenient.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat cataractous medicine.
Background technology
Cataract is that crystalline lens occurs muddyly to become opaquely by transparent in eyes, hinders light and enters ophthalmic, thereby affected vision.Initial stage muddiness is little to eyesight influence, then gradually increases the weight of, and obviously affects one's power of vision even blind.Worldwide cataract is the primary cause of disease of blinding, nearly 2,000 ten thousand people are blindings due to cataract in the world now, separately have 100,000,000 cataract patients to need surgery recovery vision, in most Africa and Asian countries, cataract at least accounts for blind person's half.The cataractous medicament categories for the treatment of is numerous at present, for example publication number is: CN1159936, name is called the Chinese invention patent application of " medicine of a kind of prevention and treatment ocular disease ", this disclosure of the invention a kind of for preventing and treat the Chinese medicine of ocular disease, this medicine contains Rhizoma Coptidis, Radix Scutellariae, Flos Inulae, the Radix Aucklandiae, Bombyx mori L., Cortex Phellodendri, Rhizoma Chuanxiong, Radix Saposhnikoviae, Fructus Gardeniae, Fructus Forsythiae, Radix Platycodonis, Herba Schizonepetae, Herba Menthae, the Radix Angelicae Dahuricae, Radix Glycyrrhizae, Fructus Viticis, Periostracum Cicadae, Flos Chrysanthemi, Folium Mori, to conjunctiva, iris, cornea inflammation or cataract, hordeolum and hypermetropia, myopia, glaucoma, presbyopia, the multiple oculopathy such as cataract has preventive and therapeutic action.But the material combination too complex of this medicine.
Summary of the invention
The technical problem to be solved in the present invention is to provide the cataractous medicine of simpler, with low cost, the eutherapeutic treatment of a kind of compatibility.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats cataractous medicine, is to be made up of the raw material of following weight proportioning:
Radix Angelicae Sinensis 10～30, Radix Bupleuri 6～15, Fructus Leonuri 10～20, Fructus Lycii 10～25, Semen Plantaginis 10～25, Concha Haliotidis 15～35, Semen Cassiae 15～25, Spica Prunellae 15～35, Radix Glycyrrhizae 3～10.
The preferred weight proportioning of each raw material is:
Radix Angelicae Sinensis 15～35, Radix Bupleuri 8～13, Fructus Leonuri 12～18, Fructus Lycii 15～20, Semen Plantaginis 12～20, Concha Haliotidis 20～30, Semen Cassiae 18～22, Spica Prunellae 18～26, Radix Glycyrrhizae 4～8.
The optimum weight proportioning of each raw material is:
Radix Angelicae Sinensis 25, Radix Bupleuri 10, Fructus Leonuri 15, Fructus Lycii 18, Semen Plantaginis 18, Concha Haliotidis 25, Semen Cassiae 20, Spica Prunellae 22, Radix Glycyrrhizae 6.
The preparation method that the present invention treats cataractous medicine is: take by weight ratio raw material Radix Angelicae Sinensis, Radix Bupleuri, Fructus Leonuri, Fructus Lycii, Semen Plantaginis, Concha Haliotidis, Semen Cassiae, Spica Prunellae, Radix Glycyrrhizae, add the decocting of 8～15 times of raw material weights to boil, after water boils, slow fire boils 30～60 minutes, leaches medicinal liquid, to obtain final product.
The present invention treats in cataractous formula:
Radix Angelicae Sinensis can be enriched blood and be invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.
Radix Bupleuri has expelling pathogenic factors from the exterior to expel the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, the effect of elevate a turnable ladder yang-energy.
Fructus Leonuri has the function of promoting blood flow to regulate menstruation, liver heat removing and eyesight improving.
Fructus Lycii has effect of the liver and the kidney tonifying.
Semen Plantaginis has clearing away heat and promoting diuresis; Eliminating dampness by diuresis antidiarrheal; Improving eyesight; The effect of eliminating the phlegm.
Concha Haliotidis has calming liver and clearing heat, effect of improving eyesight removing nebula.
Semen Cassiae has the functions such as clearing away liver-fire, wind-damp dispelling, tonifying kidney and improving eyesight.
Spica Prunellae has effect of the improving eyesight of relieving inflammation or internal heat.
Radix Glycyrrhizae function cures mainly heat-clearing and toxic substances removing, expelling phlegm for arresting cough, gastral cavity abdomen etc.
The instructions of taking that the present invention treats cataractous medicine is: oral, every day twice, each serving 200～300 grams.
The present invention treats cataractous medicine take Concha Haliotidis, Semen Cassiae as principal agent, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good clearing away heat and cooling blood, smooth the liver and regulate the spleen, the kidney tonifying effect that clears away heart-fire, has good curative effect to cataract, and its raw material is simple, treating both the principal and secondary aspects of a disease, with low cost, taking convenience.
The specific embodiment
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
10 parts of Radix Angelicae Sinensis, 6 parts of Radix Bupleuri, 10 parts of Fructus Leonuris, 10 parts of Fructus Lycii, 10 parts of Semen Plantaginiss, 15 parts of Concha Haliotidis, 15 parts of Semen Cassiaes, 15 parts of Spica Prunellaes, 3 parts, Radix Glycyrrhizae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 15 times of raw material weights to boil, after water boils, slow fire boils 60 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 2
Drug weight proportioning:
30 parts of Radix Angelicae Sinensis, 15 parts of Radix Bupleuri, 20 parts of Fructus Leonuris, 25 parts of Fructus Lycii, 25 parts of Semen Plantaginiss, 35 parts of Concha Haliotidis, 25 parts of Semen Cassiaes, 35 parts of Spica Prunellaes, 10 parts, Radix Glycyrrhizae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 30 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 3
Drug weight proportioning:
25 parts of Radix Angelicae Sinensis, 10 parts of Radix Bupleuri, 15 parts of Fructus Leonuris, 18 parts of Fructus Lycii, 18 parts of Semen Plantaginiss, 25 parts of Concha Haliotidis, 20 parts of Semen Cassiaes, 22 parts of Spica Prunellaes, 6 parts, Radix Glycyrrhizae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 40 minutes, leaches medicinal liquid, to obtain final product.
Experimental example:
Below example is further set forth the present invention and treats the beneficial effect of cataractous medicine by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: cataractous experimenter's 100 examples; Wherein male 50 examples, female's 50 examples, 40～60 years old age.
B group: cataractous experimenter's 120 examples; Wherein male 65 examples, female's 55 examples, 60～75 years old age.
2, drug administration method:
The oral embodiment of the present invention 3 makes the cataractous medicine for the treatment of every day twice, each serving 300 grams, serve on 90 days.
3, efficacy evaluation:
(1) invalid: compared with before taking medicine, without significant change.
(2) effective: cataract symptom takes an evident turn for the better.
4, therapeutic effect:
Claims (4)
1. the cataractous medicine for the treatment of, it is characterized in that being made up of the raw material of following weight proportioning:
Radix Angelicae Sinensis 10～30, Radix Bupleuri 6～15, Fructus Leonuri 10～20, Fructus Lycii 10～25, Semen Plantaginis 10～25, Concha Haliotidis 15～35, Semen Cassiae 15～25, Spica Prunellae 15～35, Radix Glycyrrhizae 3～10.
2. the cataractous medicine for the treatment of according to claim 1, is characterized in that the weight proportion of each raw material is:
Radix Angelicae Sinensis 15～35, Radix Bupleuri 8～13, Fructus Leonuri 12～18, Fructus Lycii 15～20, Semen Plantaginis 12～20, Concha Haliotidis 20～30, Semen Cassiae 18～22, Spica Prunellae 18～26, Radix Glycyrrhizae 4～8.
3. the cataractous medicine for the treatment of according to claim 2, is characterized in that the weight proportion of each raw material is:
Radix Angelicae Sinensis 25, Radix Bupleuri 10, Fructus Leonuri 15, Fructus Lycii 18, Semen Plantaginis 18, Concha Haliotidis 25, Semen Cassiae 20, Spica Prunellae 22, Radix Glycyrrhizae 6.
4. according to the cataractous medicine for the treatment of described in claim 1,2 or 3, it is characterized in that its preparation method is: take by weight ratio raw material Radix Angelicae Sinensis, Radix Bupleuri, Fructus Leonuri, Fructus Lycii, Semen Plantaginis, Concha Haliotidis, Semen Cassiae, Spica Prunellae, Radix Glycyrrhizae, add the decocting of 8～15 times of raw material weights to boil, after water boils, slow fire boils 30～60 minutes, leaches medicinal liquid, to obtain final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210412093.XA CN103768244A (en) | 2012-10-25 | 2012-10-25 | Drug for treating cataract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210412093.XA CN103768244A (en) | 2012-10-25 | 2012-10-25 | Drug for treating cataract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103768244A true CN103768244A (en) | 2014-05-07 |
Family
ID=50561304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210412093.XA Pending CN103768244A (en) | 2012-10-25 | 2012-10-25 | Drug for treating cataract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103768244A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104706972A (en) * | 2015-03-03 | 2015-06-17 | 李军 | Traditional Chinese medicine preparation capable of promoting blood circulation for removing obstruction in collaterals, for treating radioactive cataract and preparation method |
| CN106110009A (en) * | 2016-07-21 | 2016-11-16 | 王太霞 | One treats cataractous Chinese medicine preparation and preparation method |
| CN107441293A (en) * | 2017-07-30 | 2017-12-08 | 冯书德 | A kind of medicine for treating cataract and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167884A (en) * | 2007-11-02 | 2008-04-30 | 王芬 | Orally-administered traditional Chinese medicinal formula for treating cataract |
| CN102397429A (en) * | 2010-09-11 | 2012-04-04 | 高英豪 | Traditional Chinese medicine composition used for treating cataract |
-
2012
- 2012-10-25 CN CN201210412093.XA patent/CN103768244A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167884A (en) * | 2007-11-02 | 2008-04-30 | 王芬 | Orally-administered traditional Chinese medicinal formula for treating cataract |
| CN102397429A (en) * | 2010-09-11 | 2012-04-04 | 高英豪 | Traditional Chinese medicine composition used for treating cataract |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104706972A (en) * | 2015-03-03 | 2015-06-17 | 李军 | Traditional Chinese medicine preparation capable of promoting blood circulation for removing obstruction in collaterals, for treating radioactive cataract and preparation method |
| CN106110009A (en) * | 2016-07-21 | 2016-11-16 | 王太霞 | One treats cataractous Chinese medicine preparation and preparation method |
| CN107441293A (en) * | 2017-07-30 | 2017-12-08 | 冯书德 | A kind of medicine for treating cataract and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103800485A (en) | Traditional Chinese medicine preparation for treating herpes simplex keratitis | |
| CN1085792A (en) | Treat bathomorphic liniment and preparation method thereof | |
| CN101559195B (en) | Epilepsy therapy capsule and preparation method thereof | |
| CN103735790A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103768244A (en) | Drug for treating cataract | |
| CN104547621A (en) | Eye protection traditional Chinese medicine | |
| CN102824467A (en) | Drug for treating amblyopia | |
| CN102579991B (en) | Traditional Chinese medicine composition for treating herpes simplex viral keratitis | |
| CN103301286A (en) | Drug for treating dry eyes and twitching of eyelid | |
| CN102631632A (en) | Preparation method of traditional Chinese medicine lotion for treating blood stasis type pustule on sole | |
| CN102370942B (en) | Traditional Chinese medicine composition for treating epilepsy | |
| CN103405609B (en) | Traditional Chinese medicine preparation for treating cataract | |
| CN106344827A (en) | Eye drops for treating presbyopia and preparation method of eye drops | |
| CN105963635A (en) | Traditional Chinese medicinal composition for treating headache | |
| CN105106491A (en) | Traditional Chinese medicine foot bath powder capable of improving sleep and preparation and use methods thereof | |
| CN103830513A (en) | Traditional Chinese medicine preparation for treating primary glaucoma | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN102755549A (en) | Drug for curing cataract and preparation method thereof | |
| CN105125778A (en) | Sleep improvement and fatigue relief footbath powder and preparation and utilization method thereof | |
| CN105194279A (en) | Drug for treating dry eye syndrome | |
| CN103768353A (en) | Drug for treating trachoma | |
| CN105663522A (en) | Traditional Chinese medicinal composition for treating paralytic strabismus | |
| CN103768372A (en) | Drug for treating presbyopia | |
| CN104623406B (en) | Treat the Chinese medicinal formulae of iridocyclitis | |
| CN103845510A (en) | Traditional Chinese medicine for treating corneal ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |